REPORT ID 3473

Asia-Pacific Ganciclovir Market Report 2017

Publish Date
13-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the Asia-Pacific Ganciclovir market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Ganciclovir for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Ganciclovir market competition by top manufacturers/players, with Ganciclovir sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche
    Bausch & Lomb
    Fresenius Kabi
    Luitpold
    Huatai Pharmaceutical
    Wuhan Hualong Bio-pharmaceutical
    Luoxin
    HUBEI KEYI
    Tungshun Group
    Tiantianming

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Injection
    Oral

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    AIDS
    Tube transplant
    Malignant neoplasms
    CMV Infection

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Ganciclovir Market Report 2017
1 Ganciclovir Overview
    1.1 Product Overview and Scope of Ganciclovir
    1.2 Classification of Ganciclovir by Product Category
        1.2.1 Asia-Pacific Ganciclovir Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Ganciclovir Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Injection
        1.2.4 Oral
    1.3 Asia-Pacific Ganciclovir Market by Application/End Users
        1.3.1 Asia-Pacific Ganciclovir Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 AIDS
        1.3.3 Tube transplant
        1.3.4 Malignant neoplasms
        1.3.5 CMV Infection
    1.4 Asia-Pacific Ganciclovir Market by Region
        1.4.1 Asia-Pacific Ganciclovir Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Ganciclovir (2012-2022)
        1.5.1 Asia-Pacific Ganciclovir Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Ganciclovir Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Ganciclovir Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Ganciclovir Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Ganciclovir Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Ganciclovir Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Ganciclovir (Volume and Value) by Type
        2.2.1 Asia-Pacific Ganciclovir Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Ganciclovir Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Ganciclovir (Volume) by Application
    2.4 Asia-Pacific Ganciclovir (Volume and Value) by Region
        2.4.1 Asia-Pacific Ganciclovir Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Ganciclovir Revenue and Market Share by Region (2012-2017)

3 China Ganciclovir (Volume, Value and Sales Price)
    3.1 China Ganciclovir Sales and Value (2012-2017)
        3.1.1 China Ganciclovir Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Ganciclovir Revenue and Growth Rate (2012-2017)
        3.1.3 China Ganciclovir Sales Price Trend (2012-2017)
    3.2 China Ganciclovir Sales Volume and Market Share by Type
    3.3 China Ganciclovir Sales Volume and Market Share by Application

4 Japan Ganciclovir (Volume, Value and Sales Price)
    4.1 Japan Ganciclovir Sales and Value (2012-2017)
        4.1.1 Japan Ganciclovir Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Ganciclovir Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Ganciclovir Sales Price Trend (2012-2017)
    4.2 Japan Ganciclovir Sales Volume and Market Share by Type
    4.3 Japan Ganciclovir Sales Volume and Market Share by Application

5 South Korea Ganciclovir (Volume, Value and Sales Price)
    5.1 South Korea Ganciclovir Sales and Value (2012-2017)
        5.1.1 South Korea Ganciclovir Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Ganciclovir Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Ganciclovir Sales Price Trend (2012-2017)
    5.2 South Korea Ganciclovir Sales Volume and Market Share by Type
    5.3 South Korea Ganciclovir Sales Volume and Market Share by Application

6 Taiwan Ganciclovir (Volume, Value and Sales Price)
    6.1 Taiwan Ganciclovir Sales and Value (2012-2017)
        6.1.1 Taiwan Ganciclovir Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Ganciclovir Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Ganciclovir Sales Price Trend (2012-2017)
    6.2 Taiwan Ganciclovir Sales Volume and Market Share by Type
    6.3 Taiwan Ganciclovir Sales Volume and Market Share by Application

7 India Ganciclovir (Volume, Value and Sales Price)
    7.1 India Ganciclovir Sales and Value (2012-2017)
        7.1.1 India Ganciclovir Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Ganciclovir Revenue and Growth Rate (2012-2017)
        7.1.3 India Ganciclovir Sales Price Trend (2012-2017)
    7.2 India Ganciclovir Sales Volume and Market Share by Type
    7.3 India Ganciclovir Sales Volume and Market Share by Application

8 Southeast Asia Ganciclovir (Volume, Value and Sales Price)
    8.1 Southeast Asia Ganciclovir Sales and Value (2012-2017)
        8.1.1 Southeast Asia Ganciclovir Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Ganciclovir Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Ganciclovir Sales Price Trend (2012-2017)
    8.2 Southeast Asia Ganciclovir Sales Volume and Market Share by Type
    8.3 Southeast Asia Ganciclovir Sales Volume and Market Share by Application

9 Australia Ganciclovir (Volume, Value and Sales Price)
    9.1 Australia Ganciclovir Sales and Value (2012-2017)
        9.1.1 Australia Ganciclovir Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Ganciclovir Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Ganciclovir Sales Price Trend (2012-2017)
    9.2 Australia Ganciclovir Sales Volume and Market Share by Type
    9.3 Australia Ganciclovir Sales Volume and Market Share by Application

10 Asia-Pacific Ganciclovir Players/Suppliers Profiles and Sales Data
    10.1 Roche
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Ganciclovir Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Roche Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Bausch & Lomb
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Ganciclovir Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Bausch & Lomb Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Fresenius Kabi
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Ganciclovir Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Fresenius Kabi Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Luitpold
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Ganciclovir Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Luitpold Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Huatai Pharmaceutical
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Ganciclovir Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Huatai Pharmaceutical Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Wuhan Hualong Bio-pharmaceutical
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Ganciclovir Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Wuhan Hualong Bio-pharmaceutical Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Luoxin
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Ganciclovir Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Luoxin Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 HUBEI KEYI
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Ganciclovir Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 HUBEI KEYI Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Tungshun Group
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Ganciclovir Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Tungshun Group Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Tiantianming
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Ganciclovir Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Tiantianming Ganciclovir Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview

11 Ganciclovir Manufacturing Cost Analysis
    11.1 Ganciclovir Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Ganciclovir

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Ganciclovir Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Ganciclovir Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific Ganciclovir Market Forecast (2017-2022)
    15.1 Asia-Pacific Ganciclovir Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Ganciclovir Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Ganciclovir Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Ganciclovir Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Ganciclovir Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Ganciclovir Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Ganciclovir Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Ganciclovir Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Ganciclovir Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Ganciclovir Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Ganciclovir Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Ganciclovir Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Ganciclovir Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Ganciclovir Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Ganciclovir Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Ganciclovir Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Ganciclovir Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Ganciclovir Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Ganciclovir Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer